Oxygenta Pharmaceutical Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|
| Revenue | 15.30 | 49.52 | 33.69 |
| Operating Expense | 21.98 | 51.42 | 37.56 |
| Net Profit | -6.11 | -2.15 | -3.93 |
| Net Profit Margin | -39.93 | -4.34 | -11.67 |
| Earning Per Share | -1.65 | -0.60 | 1.07 |
| EBIDTA | -4.63 | -0.09 | -2.83 |
| Effective Tax Rate | TBA | -8.42 | TBA |
| Particulars | Jun 2025 |
|---|---|
| Revenue | 15.30 |
| Operating Expense | 21.98 |
| Net Profit | -6.11 |
| Net Profit Margin | -39.93 |
| Earning Per Share | -1.65 |
| EBIDTA | -4.63 |
| Effective Tax Rate | TBA |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Total Revenue Annual | 109.30 | 39.64 | 30.99 |
| Operating Expenses Annual | 119.24 | 49.34 | 38.10 |
| Operating Profit Annual | -8.96 | -9.62 | -7.83 |
| Interest Annual | 1.78 | 1.59 | 1.49 |
| Depreciation | 0.82 | 2.66 | 2.05 |
| Net Profit Annual | -9.68 | -3.48 | -11.57 |
| Tax Annual | -1.87 | -10.39 | 0.20 |
| Particulars | Mar 2025 |
|---|---|
| Total Revenue Annual | 109.30 |
| Operating Expenses Annual | 119.24 |
| Operating Profit Annual | -8.96 |
| Interest Annual | 1.78 |
| Depreciation | 0.82 |
| Net Profit Annual | -9.68 |
| Tax Annual | -1.87 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Cash Flow at the Beginning | 0.10 | 0.11 | 0.16 |
| Cash Flow from Operations | 2.60 | -13.05 | -1.63 |
| Cash Flow from Investing | -11.25 | -4.09 | -9.64 |
| Cash Flow from Financing | 8.67 | 17.13 | 11.22 |
| Cash Flow at the End | 0.12 | 0.10 | 0.11 |
| Particulars | Mar 2025 |
|---|---|
| Cash Flow at the Beginning | 0.10 |
| Cash Flow from Operations | 2.60 |
| Cash Flow from Investing | -11.25 |
| Cash Flow from Financing | 8.67 |
| Cash Flow at the End | 0.12 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| PBDIT Margin (%) | -7.97 | -24.27 | -25.27 |
| PBIT Margin (%) | -8.72 | -30.98 | -31.88 |
| PBT Margin (%) | -4.43 | -11.50 | -10.49 |
| Net PROFIT Margin (%) | -8.86 | -8.78 | -37.33 |
| Return On Networth / Equity (%) | TBA | TBA | TBA |
| Return On Networth /Employed (%) | TBA | TBA | TBA |
| Return On Assets (%) | -25.51 | -10.97 | -48.16 |
| Total Debt / Equity (X) | TBA | TBA | TBA |
| Asset Turnover Ratio (%) | 2.88 | 1.25 | 1.29 |
| Particulars | Mar 2025 |
|---|---|
| PBDIT Margin (%) | -7.97 |
| PBIT Margin (%) | -8.72 |
| PBT Margin (%) | -4.43 |
| Net PROFIT Margin (%) | -8.86 |
| Return On Networth / Equity (%) | TBA |
| Return On Networth /Employed (%) | TBA |
| Return On Assets (%) | -25.51 |
| Total Debt / Equity (X) | TBA |
| Asset Turnover Ratio (%) | 2.88 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Fixed Assets Annual | 39.63 | 29.36 | 27.91 |
| Total Current Assets Annual | 30.94 | 24.11 | 25.01 |
| Non Current Assets Annual | 52.48 | 39.09 | 29.26 |
| Total Shareholders Funds Annual | -25.02 | -20.12 | -46.20 |
| Total Assets Annual | 83.42 | 63.19 | 54.26 |
| Particulars | Mar 2025 |
|---|---|
| Fixed Assets Annual | 39.63 |
| Total Current Assets Annual | 30.94 |
| Non Current Assets Annual | 52.48 |
| Total Shareholders Funds Annual | -25.02 |
| Total Assets Annual | 83.42 |
No Data Availabe
